CIK 0000025743 · Non-accelerated filer<br>Smaller reporting company
TherapeuticsMD, Inc.
Sign in to watch- Ticker
- TXMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 870233535
- Phone
- 561-961-1900
- Business address
- 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
- Former names
- AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-26 | Donegan Michael C Prin. Fin. and Acctg. Officer | Option exercise · Performance Stock Units | −1,140 | 0 | ||
| 2023-01-24 | Donegan Michael C Prin. Fin. and Acctg. Officer | Sale | −7 | $5.31 | $37 | 7,610 |
| 2023-01-23 | Donegan Michael C Prin. Fin. and Acctg. Officer | Option exercise | +380 | 4,934 | ||
| 2023-01-23 | Donegan Michael C Prin. Fin. and Acctg. Officer | Option exercise | +1,066 | 6,000 | ||
| 2023-01-23 | Donegan Michael C Prin. Fin. and Acctg. Officer | Option exercise | +519 | 6,519 | ||
| 2023-01-23 | Donegan Michael C Prin. Fin. and Acctg. Officer | Option exercise | +2,400 | 8,919 | ||
| 2023-01-23 | Donegan Michael C Prin. Fin. and Acctg. Officer | Sale | −1,302 | $5.34 | $7K | 7,617 |
| 2023-01-23 | Donegan Michael C Prin. Fin. and Acctg. Officer | Option exercise · Restricted Stock Units | −380 | 0 | ||
| 2023-01-23 | Donegan Michael C Prin. Fin. and Acctg. Officer | Option exercise · Restricted Stock Units | −1,066 | 0 | ||
| 2023-01-23 | Donegan Michael C Prin. Fin. and Acctg. Officer | Option exercise · Restricted Stock Units | −519 | 0 | ||
| 2023-01-23 | Donegan Michael C Prin. Fin. and Acctg. Officer | Option exercise · Restricted Stock Units | −2,400 | 0 | ||
| 2022-12-30 | Rubric Capital Management LP Director | Returned to the company | −29,000 | $1,333.00 | $38.7M | 0 |
| 2022-12-30 | Rubric Capital Management LP 10% owner | Sale | −29,000 | $1,333.00 | $38.7M | 0 |
| 2022-12-09 | Rubric Capital Management LP 10% owner | Purchase | +14,825 | $6.09 | $90K | 1,757,191 |
| 2022-12-09 | Bernick Brian Co-Chief Executive Officer | Sale | −320 | $6.31 | $2K | 3,872 |
| 2022-12-08 | Rubric Capital Management LP 10% owner | Purchase | +300 | $5.83 | $2K | 1,742,366 |
| 2022-12-07 | Rubric Capital Management LP 10% owner | Purchase | +20,113 | $5.66 | $114K | 1,742,066 |
| 2022-12-07 | Naughton Gail K Director | Sale | −3,922 | $5.26 | $21K | 0 |
| 2022-12-06 | Bernick Brian Co-Chief Executive Officer | Option exercise | +3,167 | 5,127 | ||
| 2022-12-06 | Bernick Brian Co-Chief Executive Officer | Sale | −935 | $4.92 | $5K | 4,192 |
Page 4 of 11 · 206 trades